Newsroom

Feather of the toxic mountain fathead and a plate culture.
News
Bacteria are a valuable source for the discovery of natural products that can be used for the development of new drugs. A HIPS research team has now identified two new classes of active substances with antimicrobial properties from bacteria that live in symbiosis with a toxic bird. This strategy and the substances discovered offer promising avenues towards the development of new anti-infectives, particularly against antibiotic-resistant pathogens. The researchers published their findings in the journal Nature Communications. The HIPS is a site of the Helmholtz Centre for Infection Research (HZI) in collaboration with Saarland University.
07.10.2024
Plakat
News
The Helmholtz Centre for Infection Research (HZI) and the Friends of the HZI are presenting the first event in the Vienna “Sounds and Science” series in cooperation with the Staatstheater Braunschweig. A string quartet consisting of members of the Vienna Philharmonic, including concertmaster Rainer Honeck, will perform works by Mozart, Schubert, Brahms, Strauss and Beethoven, alternating with lectures by renowned scientists from the HZI. The concert will take place on 25 October 2024 at 7:30 pm in the Kleines Haus of the Staatstheater Braunschweig and will be moderated by the well-known actor Andreas Pietschmann.
30.09.2024
Elderly lady receives vaccination in the upper arm
News
So-called high-dose flu vaccines are available for older people. The reason: their immune system does not always respond sufficiently well to the standard flu vaccines. Why this is the case and the molecular processes behind it are not yet understood. However, in their current research work, scientists from the Centre for Individualised Infection Medicine (CiiM), a joint initiative of the Helmholtz Centre for Infection Research (HZI) and Hannover Medical School (MHH), using a cohort study with around 230 participants over the age of 65, have now been able to identify key molecules. The researchers hope that their findings will help to further increase the immune response to the flu vaccine in older people in the future. The study has been published in the journal “Science Advances”.
30.09.2024
On 21 September 2024 the HZI is holding an Open Day
News
On Saturday, September 21, 2024, the Helmholtz Centre for Infection Research (HZI) in Braunschweig is holding an Open Day. All interested people will have the opportunity to visit HZI laboratories and meet scientists on the Science Campus Braunschweig-Süd in the Stöckheim district from 11 am to 4 pm. There will also be many activities especially for children. For example, they can compete in pipetting, make microbes or listen to a scientific lecture for children.
12.09.2024
Elektronenmikroskopische Aufnahme von Viruspartikeln des Grippeerregers Influenza.
News
Annual flu vaccines protect against severe infection, but they vary in efficacy and may not match the most virulent strains of the season. The reality of a universal flu vaccine, which would protect people from all strains, and ideally longer than a single season, remains elusive. This major roadblock is addressed by the INCENTIVE consortium, which is funded by the European Commission and coordinated at the Helmholtz Centre for Infection Research (HZI) by Prof. Carlos A. Guzman. Findings published in the Journal of Virology suggest that universal flu vaccines are coming closer.
10.09.2024
Dr. Peter Sullivan in the lab.
Interview
A key focus at the Helmholtz Centre for Infection Research (HZI) and its sites like the Helmholtz Institute for Pharmaceutical Research Saarland (HIPS) is translating research findings into medical and pharmaceutical applications. Beyond scientific collaboration, the goal is to facilitate the transfer of technology and knowledge into practical and potentially commercial uses. Recently, the company MyxoTech has been founded as a HIPS spin-off. MyxoTech CEO Peter Sullivan explains what the new company is about and what it wants to achieve.
29.08.2024

HZI in the media

der Medizinischen Hochschule Hannover und des Helmholtz-Zentrums für Infektionsforschung wollen seltene rheumatische Erkrankungen des

02.02.2026
|
Niedersächsisches Landesjustizportal

MWK) und der VolkswagenStiftung hat das Helmholtz-Zentrum für Infektionsforschung (HZI) in Braunschweig das Großprojekt HUMAN ...

02.02.2026
|
juraforum.de

... an anderen Forschungseinrichtungen gearbeitet, beispielsweise am Helmholtz-Institut für Pharmazeutische Forschung Saarland. Was sind die ...

02.02.2026
|
Deutschlandfunk

waren mehrere Forschungseinrichtungen beteiligt, darunter das Helmholtz-Zentrum für Infektionsforschung . Die Ergebnisse erschienen im

02.02.2026
|
Münchner Merkur

Medicine (CiiM), which is a joint institution of the Helmholtz Center for Infection Research (HZI) and Hannover Medical School (MHH). Using

29.01.2026
|
Medical Xpress

... stumpfen ab“, erklärt Marc Brönstrup vom Helmholtz-Zentrum für Infektionsforschung in Braunschweig. Neue Antibiotika sind dringend ...

27.01.2026
|
Tvinfo.de

entered an exclusive research partnership with the Helmholtz Centre for Infection Research’s HIPS institute to investigate how the skin

22.01.2026
|
Simply Wall St News

... der MHH, des TWINCORE Hannover und des Helmholtz-Instituts für Infektionsforschung (HZI). Ihre wissenschaftliche Expertise ...

21.01.2026
|
hannover.de

... auch Teil des Ecoversity-Programms der Technischen Universität Braunschweig.

 

GN De hlth| Source | domain www.helmholtz-hzi.

20.01.2026
|
Die heutigen Nachrichten

... validierte Daten der MHH und des Helmholtz-Zentrum für Infektionsforschung (HZI), die zeitnah in Fachjournalen veröffentlichet ...

19.01.2026
|
wallstreet:online

institutions, including Hannover Medical School and the Helmholtz Centre for Infection Research in Germany, the University of Duisburg Essen

18.01.2026
|
Thailandmedical

Lange , Kommissarische Leiterin der Abteilung Epidemiologie am Helmholtz-Zentrum für Infektionsforschung (HZI), Braunschweig, gegenüber dem

16.01.2026
|
Medscape

Register now for the HZI-Newsletter